BACKGROUND AND OBJECTIVES: Several epidemiologic studies have investigated the relationship between the polymorphisms of ERBB2 gene and breast cancer risk. However, the results are inconclusive. This meta-analysis aimed to assess the association between ERBB2 Ile655Val and Ala1170Pro polymorphisms and the susceptibility to breast cancer. METHODS: Twenty-six studies including 15,940 cases and 19,148 controls were analyzed in this meta-analysis. RESULTS: Overall, allele contrast (Val vs. Ile) of ERBB2 655 polymorphism produced significant results in worldwide populations (OR = 1.123, 95%CI = 1.01-1.249) and in Caucasian populations (OR = 1.149, 95%CI = 1.002-1.318). In addition, the Val/Val genotype of ERBB2 655 polymorphism was associated with an increase risk of breast cancer in African (Val/Val vs. Ile/Ile OR = 16.031 95%CI = 2.019-127.267; Val/Val vs. Ile/Val + Ile/Ile OR = 16.445 95%CI = 2.059-131.351), but not in Caucasian or Asian individuals. CONCLUSIONS: ERBB2 655 Val allele would be a risk factor for breast cancer, especially in Caucasian populations. In addition, the Val/Val genotype was a risk factor for breast cancer in African individuals. ERBB2 Ala1170Pro was not associated with breast cancer susceptibility.
BACKGROUND AND OBJECTIVES: Several epidemiologic studies have investigated the relationship between the polymorphisms of ERBB2 gene and breast cancer risk. However, the results are inconclusive. This meta-analysis aimed to assess the association between ERBB2 Ile655Val and Ala1170Pro polymorphisms and the susceptibility to breast cancer. METHODS: Twenty-six studies including 15,940 cases and 19,148 controls were analyzed in this meta-analysis. RESULTS: Overall, allele contrast (Val vs. Ile) of ERBB2 655 polymorphism produced significant results in worldwide populations (OR = 1.123, 95%CI = 1.01-1.249) and in Caucasian populations (OR = 1.149, 95%CI = 1.002-1.318). In addition, the Val/Val genotype of ERBB2 655 polymorphism was associated with an increase risk of breast cancer in African (Val/Val vs. Ile/Ile OR = 16.031 95%CI = 2.019-127.267; Val/Val vs. Ile/Val + Ile/Ile OR = 16.445 95%CI = 2.059-131.351), but not in Caucasian or Asian individuals. CONCLUSIONS:ERBB2 655 Val allele would be a risk factor for breast cancer, especially in Caucasian populations. In addition, the Val/Val genotype was a risk factor for breast cancer in African individuals. ERBB2 Ala1170Pro was not associated with breast cancer susceptibility.
Authors: Rafał Watrowski; Dan Cacsire Castillo-Tong; Eva Schuster; Michael B Fischer; Paul Speiser; Robert Zeillinger Journal: Tumour Biol Date: 2015-12-14
Authors: Tung Nguyen Thanh; Bao Song Nguyen Tran; Ai Phuong Hoang Thi; Thang Tran Binh; Thong Ba Nguyen; Tam Le Minh; Quoc Huy Nguyen Vu; Thuan Dang Cong Journal: Asian Pac J Cancer Prev Date: 2021-01-01
Authors: Carla Solange Escórcio-Dourado; Francisco Adelton Alves-Ribeiro; Jose Charles Lima-Dourado; Alesse Ribeiro Dos Santos; Renato de Oliveira Pereira; Cleciton Braga Tavares; Vladimir Costa Silva; Pedro Vitor Lopes Costa; José Maria Soares-Júnior; Benedito Borges da Silva Journal: Clinics (Sao Paulo) Date: 2020-12-09 Impact factor: 2.365
Authors: Giovana T Torrezan; Fernanda G Dos Santos R de Almeida; Márcia C P Figueiredo; Bruna D de Figueiredo Barros; Cláudia A A de Paula; Renan Valieris; Jorge E S de Souza; Rodrigo F Ramalho; Felipe C C da Silva; Elisa N Ferreira; Amanda F de Nóbrega; Paula S Felicio; Maria I Achatz; Sandro J de Souza; Edenir I Palmero; Dirce M Carraro Journal: Front Genet Date: 2018-05-07 Impact factor: 4.599